Corient Private Wealth’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-10,000
Closed -$164K – 2153
2023
Q2
$164K Sell
10,000
-48
-0.5% -$1.98K ﹤0.01% 1911
2023
Q1
$169K Buy
+10,048
New +$423K ﹤0.01% 1818

Other funds holding BME

Corient Private Wealth's BME Position: Q3 2023 in Review

Corient Private Wealth sold out of BlackRock Health Sciences Trust (BME) in Q3 2023, closing a stake of 10,000 shares — an estimated $164K sold.

Corient Private Wealth first reported a position in BME in Q1 2023 and held it in 2 quarters. The position peaked at $169K in Q1 2023. 72 funds tracked by Wall St. Rank hold BME as of Q3 2023.

  • Corient Private Wealth reported no remaining BlackRock Health Sciences Trust position as of Q3 2023 after selling out during the quarter.
  • Corient Private Wealth sold 10,000 BlackRock Health Sciences Trust shares in Q3 2023, an estimated $164K.
  • Corient Private Wealth first reported a position in BlackRock Health Sciences Trust in Q1 2023 and held it in 2 quarters.
  • Corient Private Wealth's BlackRock Health Sciences Trust position peaked at $169K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2023.

Based on Corient Private Wealth's 13F filing for Q3 2023, filed 3 Nov 2023.